![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Changes in cognitive function over 96 weeks after initiating darunavir/ritonavir with either raltegravir or tenofovir-emtricitabine; NEAT 001 / ANRS 143 randomised controlled study
|
|
|
Reported by Jules Levin
EACS 2015 Oct 21-24 Barcelona, Spain -15th European AIDS Conference
Alan Winston, Wolfgang Stöhr, Andrea Antinori, Helene Amieva, Philippe Perré, Stephane De Wit, Jacques Reynes, Mark Gompels, Antonella d'Arminio Monforte, Jose-Maria Gatell, Anton Pozniak, Abdel Babiker, François Raffi and Laura Richert for the NEAT 001/ANRS 143 Study Group
![EACS1.gif](../images/102615/102615-9/EACS1.gif)
![EACS2.gif](../images/102615/102615-9/EACS2.gif)
![EACS3.gif](../images/102615/102615-9/EACS3.gif)
![EACS4.gif](../images/102615/102615-9/EACS4.gif)
![EACS5.gif](../images/102615/102615-9/EACS5.gif)
![EACS6.gif](../images/102615/102615-9/EACS6.gif)
![EACS7.gif](../images/102615/102615-9/EACS7.gif)
![EACS8.gif](../images/102615/102615-9/EACS8.gif)
![EACS9.gif](../images/102615/102615-9/EACS9.gif)
![EACS10.gif](../images/102615/102615-9/EACS10.gif)
![EACS11.gif](../images/102615/102615-9/EACS11.gif)
![EACS12.gif](../images/102615/102615-9/EACS12.gif)
![EACS13.gif](../images/102615/102615-9/EACS13.gif)
![EACS14.gif](../images/102615/102615-9/EACS14.gif)
![EACS15.gif](../images/102615/102615-9/EACS15.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|